Silica nanoparticles induce alpha-synuclein induction and aggregation in PC12-cells

Area of Science:

• Nanotechnology
• Neuroscience
• Toxicology

Background:

• Silica nanoparticles (SiO2-NPs) are utilized in brain disease diagnosis and drug delivery.
• Previous research confirmed SiO2-NPs penetrate the brain and target dopaminergic neurons.
• The neurotoxicity and potential role of SiO2-NPs in Parkinson's disease (PD) development are unknown.

Purpose of the Study:

• To investigate the neurotoxic effects of SiO2-NPs on dopaminergic neuron-like PC12 cells.
• To determine if SiO2-NPs contribute to Parkinson's disease pathogenesis.

Main Methods:

• Exposure of PC12 cells to SiO2-NPs.
• Assessment of α-synuclein expression, proteasome activity, and ubiquitin-proteasome system (UPS) protein levels.
• Analysis of autophagy markers (LC3-II, Beclin 1) and signaling pathways (PI3K/Akt/mTOR).

Main Results:

• SiO2-NPs upregulated α-synuclein expression and inhibited UPS function, decreasing Parkin and UCHL1.
• SiO2-NPs induced autophagy by inhibiting the PI3K-Akt-mTOR signaling pathway.
• N-acetyl cysteine treatment reduced SiO2-NP-induced α-synuclein upregulation.

Conclusions:

• SiO2-NPs induce oxidative stress and α-synuclein aggregation via UPS inhibition.
• SiO2-NPs promote autophagy through the PI3K-Akt-mTOR pathway.
• SiO2-NP exposure may represent a significant risk factor for Parkinson's disease development.